Gastrointestinal Stromal Tumor

  • Kyle Perry
Chapter
Part of the Pathology for Clinicians book series (PACLIN)

Abstract

The gastrointestinal tract (GI) can be affected by many of the same soft tissue neoplasms that involve other parts of the body, such as leiomyosarcoma, leiomyoma, schwannoma, and perineurioma. A few soft tissue neoplasms, however, are unique to the gastrointestinal tract. Of these, gastrointestinal stromal tumor is one of the most common. This tumor emanates from the interstitial cells of Cajal that normally coordinate peristalsis for digestion.

Keywords

Gastrointestinal stromal tumor (GIST) 

References

  1. 1.
    Tryggvason G, Gislason HG, Magnusson MK, Jonasson JG. Gastrointestinal stromal tumors in Iceland, 1990–2003: the icelandic GIST study, a population-based incidence and pathologic risk stratification study. Int J Cancer. 2005;117(2):289–93.CrossRefPubMedGoogle Scholar
  2. 2.
    Emile JF, Brahimi S, Coindre JM, Bringuier PP, Monges G, Samb P, et al. Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs. Med Oncol. 2012;29(3):1765–72.CrossRefPubMedGoogle Scholar
  3. 3.
    Hornick JL, editor. Practical soft tissue pathology: a diagnostic approach. 1st ed. Philadelphia: Saunders; 2013.Google Scholar
  4. 4.
    Miettinen M, Fetsch JF, Sobin LH, Lasota J. Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases. Am J Surg Pathol. 2006;30(1):90–6.CrossRefPubMedGoogle Scholar
  5. 5.
    Nishida T, Hirota S, Taniguchi M, Hashimoto K, Isozaki K, Nakamura H, et al. Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nat Genet. 1998;19(4):323–4.CrossRefPubMedGoogle Scholar
  6. 6.
    Stratakis CA, Carney JA. The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications. J Intern Med. 2009;266(1):43–52.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Miettinen M, Wang ZF, Lasota J. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. Am J Surg Pathol. 2009;33(9):1401–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Hornick JL, editor. Practical soft tissue pathology: a diagnostic approach. Philadelphia: Saunders; 2013.Google Scholar
  9. 9.
    Patil DT, Rubin BP. Genetics of gastrointestinal stromal tumors: a heterogeneous family of tumors? Surg Pathol Clin. 2015;8(3):515–24.CrossRefPubMedGoogle Scholar
  10. 10.
    Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol. 2005;29(1):52–68.CrossRefPubMedGoogle Scholar
  11. 11.
    Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol. 2008;39(10):1411–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Joensuu H, Vehtari A, Riihimaki J, Nishida T, Steigen SE, Brabec P, et al. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol. 2012;13(3):265–74.CrossRefPubMedGoogle Scholar
  13. 13.
    Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006;23(2):70–83.CrossRefPubMedGoogle Scholar
  14. 14.
    Debiec-Rychter M, Sciot R, Le Cesne A, Schlemmer M, Hohenberger P, van Oosterom AT, et al. KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours. Eur J Cancer. 2006;42(8):1093–103.CrossRefPubMedGoogle Scholar
  15. 15.
    Heinrich MC, Maki RG, Corless CL, Antonescu CR, Harlow A, Griffith D, et al. Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor. J Clin Oncol. 2008;26(33):5352–9.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Kyle Perry
    • 1
  1. 1.Department of PathologyUniversity of Manitoba Max Rady College of MedicineWinnipegCanada

Personalised recommendations